Search

Meeting Coverage:

Duke Advanced Vitreous Surgery Courses

AVS: 2019

Intraocular Sustained Drug Delivery in 2019

Glenn Jaffe, MD

Show Description +

Glenn Jaffe, MD, provides an overview of his presentation on intraocular sustained drug delivery implants at Duke AVS 2019. Dr. Jaffe outlines the various sustained drug delivery implants that are available and details the strengths of the next generation of implants in the pipeline.

Posted: 4/26/2019

Up Next

Should We Treat All Patients With Diabetic Retinopathy?

Should We Treat All Patients With Diabetic Retinopathy?

Sophie Bakri, MD

Myopic Foveoschisis: When to Operate and on Whom

Myopic Foveoschisis: When to Operate and on Whom

Ramin Tadayoni, MD, PhD

Myopic Traction Maculopathy: New Classification and Guidelines to Treatment

Myopic Traction Maculopathy: New Classification and Guidelines to Treatment

Barbara Parolini, MD

How and Why to Get Involved With Investigator Sponsored Trials

How and Why to Get Involved With Investigator Sponsored Trials

Rishi Singh, MD

A Potential New Method of Measuring Metamorphopsia

A Potential New Method of Measuring Metamorphopsia

Andrew Moshfeghi, MD, MBA

Performing a Diagnostic Vitrectomy

Performing a Diagnostic Vitrectomy

Dilraj Grewal, MD

Annual Duke fAVS Course and Wetlab: A Valuable Experience

Annual Duke fAVS Course and Wetlab: A Valuable Experience

Lejla Vajzovic, MD

Back to All Videos

Intraocular Sustained Drug Delivery in 2019

Glenn Jaffe, MD

Glenn Jaffe, MD, provides an overview of his presentation on intraocular sustained drug delivery implants at Duke AVS 2019. Dr. Jaffe outlines the various sustained drug delivery implants that are available and details the strengths of the next generation of implants in the pipeline.

Posted: 4/26/2019

Please log in to leave a comment.

More From AVS: 2019 Coverage

Annual Duke fAVS Course and Wetlab: A Valuable Experience

Annual Duke fAVS Course and Wetlab: A Valuable Experience

Lejla Vajzovic, MD

Should We Treat All Patients With Diabetic Retinopathy?

Should We Treat All Patients With Diabetic Retinopathy?

Sophie Bakri, MD

Myopic Foveoschisis: When to Operate and on Whom

Myopic Foveoschisis: When to Operate and on Whom

Ramin Tadayoni, MD, PhD

Myopic Traction Maculopathy: New Classification and Guidelines to Treatment

Myopic Traction Maculopathy: New Classification and Guidelines to Treatment

Barbara Parolini, MD

Bryn Mawr Communications, LLC, and Eyetube.net are not affiliated with the official program of AVS: 2019.